Pityriasis rosea
Also known as: Pityriasis rosea of Gibert, Gibert disease, Acute self-limiting papulosquamous eruption
Pityriasis rosea is an acute, typically self-limiting scaly eruption. It is classically characterised by an initial 'herald patch' followed by smaller, ovoid lesions on the trunk. Diagnosis is primarily clinical; atypical presentations require assessment for mimics, including fungal infection, drug-related eruptions, and secondary syphilis. Conventional management prioritises diagnostic reassurance and symptomatic relief of pruritus. TCM frameworks may provide an adjunctive approach for symptom support, although the cited evidence does not evaluate acupuncture or herbal medicine for this condition. A Mendelian randomisation study regarding vitamin A does not establish the clinical utility or safety of supplementation, and research into COVID-19-associated rashes is not a pityriasis rosea treatment study. The traditional patterns described are clinical constructs rather than validated biomedical subtypes.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Utilise brief, lukewarm showers with soap-free cleansers and fragrance-free emollients; avoid mechanical irritation or vigorous exfoliation of the lesions.
- •Adopt loose-fitting, breathable attire and maintain a cool ambient temperature, as diaphoresis may exacerbate pruritus.
- •Maintain short fingernails and apply cool compresses as an alternative to scratching; clinical monitoring of pruritus-related sleep disturbance is recommended.
- •Maintain a balanced nutritional intake; avoid initiating vitamin A supplementation or restrictive elimination diets, as current evidence does not support their efficacy for this condition.
Cautions & Contraindications
- •Do not recommend high-dose vitamin A on the basis of the Mendelian-randomisation findings. Genetic associations do not establish supplementation efficacy or safety; the reported multivariable confidence interval is very imprecise and crosses 1. Pregnancy and concurrent retinoid use require particular caution, although these safety issues were not evaluated in this abstract.[]
- •Do not extrapolate the COVID-19 rash series into evidence for antiviral treatment, acupuncture or herbal treatment of pityriasis rosea. Assess concurrent infection separately and retain indicated conventional care.[]
- •As general procedural precautions, not recommendations tested in the supplied rash series, avoid needling through inflamed, excoriated or infected skin and obtain individual assessment for pregnancy, anticoagulation, bleeding disorders or immunosuppression. Defer elective treatment during acute systemic illness.[]
When to reassess or seek care again
Record baseline distribution, photographs with consent, itch on a 0–10 scale and nights of sleep disturbed per week. Review after 1–2 weeks if adjunctive care is undertaken; assess adverse effects and whether there is a meaningful symptom benefit. Reconsider or stop treatment without benefit rather than escalating automatically. Refer earlier for diagnostic uncertainty, worsening lesions or systemic symptoms, and obtain medical reassessment if the eruption persists beyond approximately 12 weeks. Improvement during the expected self-limiting course does not demonstrate treatment efficacy.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Causal relationship between trace elements and pityriasis rosea: A Mendelian randomization analysis.Medicine · 2026
- PloS one · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
